Citicoline sodium

CAS No.: 33818-15-4

Molecular Formula: C₁₄H₂₆N₄O₁₁P₂·Na

Molecular Weight: 511.31

EINECS No.: 251-689-1

Citicoline Sodium is a nucleoside derivative, belonging to cerebral metabolic activators and neuroprotective agents. It is mainly used for central nervous system injuries, cognitive dysfunction, ocular diseases, etc., and is a core raw material in the fields of clinical medicine and health products.

Applications:

1. Neurology & Neurosurgery (Core Use)

• Acute craniocerebral injury, cerebral concussion, contusion, post-operative recovery.
• Stroke: Recovery phase of ischemic cerebral infarction and cerebral hemorrhage.
• Adjunctive therapy for neurodegenerative diseases such as Parkinson’s disease.
• Improvement of coma and disturbance of consciousness.
• 
  

2. Cognitive & Geriatric Encephalopathy

• Vascular dementia, Alzheimer’s disease: improves memory, attention and executive function.
• Senile cerebral insufficiency: dizziness, amnesia, slow response.
• 
  

3. Ophthalmology

• Glaucoma, optic nerve atrophy.
• Ischemic optic neuropathy and retinopathy.
• Protects optic nerve and improves visual function.
• 
  

4. Other Clinical Uses

• Alcohol/drug-induced encephalopathy.
• Adjunctive treatment for children with cerebral dysplasia or cerebral palsy.
• Sudden deafness and tinnitus of neurogenic origin.
• 
  

5. Dietary Supplements (Mainstream Overseas)

• Enhances learning, memory and anti-brain fatigue.
• Supports brain health and cognitive function in the elderly.
• Improves neural response and focus for athletes.
• 
  

6. Research Reagent

• Pharmacological studies on neuroprotection, cerebral ischemia and cognitive function.